Logo of National Resource Center on AD/HD
Register · NRC Library   
Ask a Question About AD/HD
Welcome
Search:
National Resource Center on AD/HD: Home
Bookmark 

and Share Become an NRC fan on Facebook

Symptoms

Medication (chart) Behavior
Schools Doctors & Directories Adults

See all What We Know sheets and Frequently Asked Questions (FAQs).

Welcome!

Did You Find What You Need?

If you don't find the answers you are looking for, call us at 1-800-233-4050 or click on Ask a question about AD/HD, found on every page of this site. Your question will be directed to one of our knowledgeable Health Information Specialists for response.

The National Resource Center on AD/HD: A Program of CHADD is the nation's clearinghouse for science-based information about all aspects of attention-deficit/hyperactivity disorder (ADHD). Funded by the Centers for Disease Control and Prevention, the NRC provides information on this disorder which affects how millions of children and adults function on a daily basis. 

Disclaimer: The information provided on this Web site is supported by Cooperative Agreement Number 5U38DD000335-03 from the Centers for Disease Control and Prevention (CDC). The contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.

© Copyright 2009

Click here to learn more about CHADD
En Español

Latest News:

News Dec 14. 2009: NIH and NIMH release data from survey that tracks rates of common mental disorders among American youth.

Sept. 29, 2009: NIH's Consumer Health Information Request for Information (RFI) helps disseminate science-based health resources to public

Sept. 16, 2009: FDA issues "Tentative Approval" for atomoxetine hydrochloride (generic of Strattera)

Sept. 2, 2009: FDA approves Intuniv (guanfacine) extended-release treating AD/HD in children 6-17 yrs

June 23, 2009: FDA and NIMH statements about AD/HD medications and sudden death

"Latest News" Archive
Print Page · Email Page · About Us · Contact Us
Terms of Use · Privacy Policy · Site Map